RETO:NASDAQReTo Eco-Solutions, Inc. Analysis
Data as of 2026-07-06 - not real-time
$2.84
Latest Price
9/10Risk
Risk Level: High
Executive Summary
RETO is trading at $2.84, comfortably above its 20‑day SMA of $2.58 and 50‑day SMA of $2.48, yet still far below the 200‑day SMA of $8.03, indicating short‑term price support but long‑term weakness. The RSI sits at 56.9, suggesting neutral momentum, while the MACD histogram is positive and the MACD signal is labeled bullish, providing a modest technical upside bias. However, the stock exhibits extreme 30‑day volatility of 131% and a staggering max drawdown of -96%, reflecting a highly unstable price environment. Fundamentals are distressed: operating margin is –67%, cash flow is negative, debt‑to‑equity is 9.85, and the company carries $2.44 M of debt against only $0.25 M of cash, raising solvency concerns. The balance sheet is further strained by a price‑to‑book ratio of 0.06, indicating the market values the firm at a fraction of its book, but this “cheapness” is driven by earnings collapse rather than hidden value. Recent corporate news disclosed a board‑approved share combination on May 13 2026, which could dilute existing shareholders and adds uncertainty to the capital structure. Overall, the mix of weak fundamentals, high leverage, and volatile price action outweighs the modest technical bullish signals, making the stock a high‑risk, value‑oriented play with limited upside.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 7/10
Key Factors
- Bullish MACD but decreasing volume
- Extreme short‑term volatility
- High debt load and negative cash flow
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- Very low price‑to‑book ratio suggesting potential floor
- Ongoing regulatory and geographic exposure
- Uncertainty around the announced share combination
Long Term
> 3 yearsCautious
Model confidence: 3/10
Key Factors
- Sustained operating losses and negative earnings
- High leverage with limited cash reserves
- Lack of dividend and no clear path to profitability
Key Metrics & Analysis
Financial Health
Revenue Growth118.90%
ROE-46.15%
ROA-5.60%
Debt/Equity9.85
P/B Ratio0.1
Op. Cash Flow$-4341056
Free Cash Flow$-2728219
Technical Analysis
TrendNeutral
RSI56.9
Support$1.85
Resistance$3.50
MA 20$2.58
MA 50$2.48
MA 200$8.03
MACDBullish
VolumeDecreasing
Fear & Greed Index93.63
Valuation
GradeUndervalued
TypeValue
Risk Assessment
Beta0.60
Volatility131.40%
Sector RiskMedium
Reg. RiskHigh
Geo RiskHigh
Currency RiskMedium
Liquidity RiskHigh
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.